Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences

Ítems similars

• Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of IGF2-P3 and IGF2-P4 regulatory sequences
  per: Amit, Doron, et al.
  Publicat: (2011)
• Development of targeted therapy for a broad spectrum of solid tumors mediated by a double promoter plasmid expressing diphtheria toxin under the control of IGF2-P4 and IGF2-P3 regulatory sequences
  per: Amit, Doron, et al.
  Publicat: (2013)
• Development of targeted therapy for a broad spectrum of cancers (pancreatic cancer, ovarian cancer, glioblastoma and HCC) mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences
  per: Amit, Doron, et al.
  Publicat: (2012)
• Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences
  per: Mizrahi, Aya, et al.
  Publicat: (2009)
• Transcriptional targeting of glioblastoma by diphtheria toxin–A driven by both H19 and IGF2-P4 promoters
  per: Amit, Doron, et al.
  Publicat: (2012)